MK Proteins Intrinsic Value
MK Proteins (MKPL) median intrinsic value is ₹8.58 from 9 valuation models (range ₹1–₹11), vs current price ₹4.29 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. For current market price and key ratios, visit MKPL share price screener.
MKPL Valuation Methods Summary — DCF, Graham Number & P/E
MK Proteins intrinsic value across 9 models vs current price ₹4.29 — upside/downside and value range per method. Read MK Proteins dividend policy for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹2.16 | ₹1.73 - ₹2.59 | -49.7% | EPS: ₹0.18, Sector P/E: 12x |
| Book Value Method | asset | ₹10.72 | ₹9.65 - ₹11.79 | +149.9% | Book Value/Share: ₹20.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹8.58 | ₹7.72 - ₹9.44 | +100.0% | Revenue/Share: ₹100.79, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹8.58 | ₹7.72 - ₹9.44 | +100.0% | EBITDA: ₹11.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹10.72 | ₹8.58 - ₹12.86 | +149.9% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹1.29 | ₹1.16 - ₹1.42 | -69.9% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1.52 | ₹1.37 - ₹1.67 | -64.6% | Revenue Growth: 10.6%, Adj P/E: 8.4x |
| ROE Based Valuation | profitability | ₹8.58 | ₹7.72 - ₹9.44 | +100.0% | ROE: 9.2%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹9.00 | ₹8.10 - ₹9.90 | +109.8% | EPS: ₹0.18, BVPS: ₹20.00 |
MKPL Intrinsic Value vs Market Price — All Valuation Models
MK Proteins fair value range ₹1–₹11 vs current market price ₹4.29 across 9 valuation models. Analyse MK Proteins shareholding analysis to track promoter, FII and institutional holdings.
MKPL Intrinsic Value Analysis — Undervalued or Overvalued?
MK Proteins median intrinsic value ₹8.58, current price ₹4.29 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of MKPL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of MK Proteins (MKPL) is ₹8.58 (median value). With the current market price of ₹4.29, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹1.29 to ₹10.72, indicating ₹1.29 - ₹10.72.
Is MKPL undervalued or overvalued?
Based on our multi-method analysis, MK Proteins (MKPL) appears to be trading below calculated value by approximately 100.0%.
MKPL Financial Health — Key Ratios vs Industry Benchmarks
MK Proteins financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 59.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 9.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 3.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.92x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
MKPL Cash Flow Quality — Operating & Free Cash Flow
MK Proteins operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-16 Cr | ₹-17 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹32 Cr | ₹29 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-10 Cr | ₹-11 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹6 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |